These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12161051)

  • 1. Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot.
    Piaggesi A; Rizzo L; Golia F; Costi D; Baccetti F; Ciaccio S; De Gregorio S; Vignali E; Trippi D; Zampa V; Marcocci C; Del Prato S
    Diabetes Res Clin Pract; 2002 Oct; 58(1):1-9. PubMed ID: 12161051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foot bone mass and analysis of calcium metabolism in diabetic patients affected by severe neuropathy.
    Barbaro D; Orsini P; Lapi P; Turco A; Pasquini C
    Minerva Endocrinol; 2008 Dec; 33(4):283-8. PubMed ID: 18923365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover.
    Jirkovská A; Kasalický P; Boucek P; Hosová J; Skibová J
    Diabet Med; 2001 Jun; 18(6):495-500. PubMed ID: 11472470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of Calcaneal Quantitative Ultrasound Parameters in Patients with Diabetes: The Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes.
    Conti F; Balducci S; Pugliese L; D'Errico V; Vitale M; Alessi E; Salerno G; Iacobini C; Menini S; Bollanti L; Nicolucci A; Pugliese G
    J Diabetes Res; 2017; 2017():4749619. PubMed ID: 29057273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
    Petrova NL; Foster AV; Edmonds ME
    Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B; Cortet C; Blanckaert F; d'Herbomez M; Marchandise X; Wémeau J-L ; Decoulx M; Dewailly D
    Osteoporos Int; 2001; 12(2):117-23. PubMed ID: 11303711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus.
    Gerdhem P; Isaksson A; Akesson K; Obrant KJ
    Osteoporos Int; 2005 Dec; 16(12):1506-12. PubMed ID: 15824889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot.
    Berendt AR; Lipsky B
    Curr Diab Rep; 2004 Dec; 4(6):424-9. PubMed ID: 15539006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure.
    Coen G; Mantella D; Calabria S; Sardella D; Manni M; Fassino V; D'Anello E; Giustini M; Taggi F
    Am J Nephrol; 2000; 20(4):283-90. PubMed ID: 10970981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic polyneuropathy relates to bone metabolism and markers of bone turnover in elderly patients with type 2 diabetes: greater effects in male patients.
    Rasul S; Ilhan A; Wagner L; Luger A; Kautzky-Willer A
    Gend Med; 2012 Jun; 9(3):187-96. PubMed ID: 22503604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic abnormalities in the feet of patients with diabetic neuropathy.
    Cavanagh PR; Young MJ; Adams JE; Vickers KL; Boulton AJ
    Diabetes Care; 1994 Mar; 17(3):201-9. PubMed ID: 8174448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot.
    Peters EJ; Lavery LA;
    Diabetes Care; 2001 Aug; 24(8):1442-7. PubMed ID: 11473084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
    Sartorio A; Ortolani S; Galbiati E; Conte G; Vangeli V; Arosio M; Porretti S; Faglia G
    J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma.
    Jakob C; Zavrski I; Heider U; Brux B; Eucker J; Langelotz C; Sinha P; Possinger K; Sezer O
    Eur J Haematol; 2002 Jul; 69(1):37-42. PubMed ID: 12270060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mass and bone resorption in postmenopausal women with type 2 diabetes mellitus.
    Hosoda H; Fukui M; Nakayama I; Asano M; Kadono M; Hasegawa G; Yoshikawa T; Nakamura N
    Metabolism; 2008 Jul; 57(7):940-5. PubMed ID: 18555835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W; Muley T; Herb KP; Schmidt-Gayk H
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.